Literature DB >> 25126349

From a to z: medication cost-management strategies for disproportionate share hospitals.

Andrea Henry1, Goldina Ikezuagu Erowele2, Uche Anadu Ndefo3, Jackie Milton-Brown4, Enock Anassi2, Wendy Green2, Adriana Alvidrez2, Alphonsus U Okpara5.   

Abstract

BACKGROUND: Harris County Hospital District, Houston, TX, is a publicly funded hospital system that provides care to residents of Harris County with a need-based payment system. The Harris County Hospital District pharmacy department, with a drug budget of more than $75 million in fiscal year 2010, utilizes a closed formulary system that is managed by the Formulary Management and Pharmacoeconomics Service, along with the medical staff. This service is comprised of clinical pharmacists whose goal is to provide a comprehensive, safe, and cost-effective formulary.
OBJECTIVE: To describe the unique formulary management process at a county hospital system and what makes this process cost-effective, which may benefit pharmacy departments in institutions serving an indigent patient population.
SUMMARY: The Harris County Hospital District drug formulary is overseen by the Pharmacy & Therapeutics committee, which is supported by 5 therapeutic subcommittees, including antimicrobials, cardiovascular, general formulary, central nervous system, and oncology. The Pharmacy & Therapeutics Committee consists of a medical staff committee that is supported by clinical pharmacists, who serve as the facilitators of these 5 subcommittees. Their responsibilities include the provision of drug information for formulary decisions, providing parameters to govern the use of certain medications, communicating changes to the formulary, conducting class reviews and medication utilization evaluations, coordinating annual pharmaceutical bids, reviewing and writing medication use policies and procedures, facilitating the use of cost-effective medications, and monitoring the use of medications in the hospital system.
CONCLUSION: The processes incorporated by Harris County Hospital District in its formulary management are cost-effective and may be beneficial to other pharmacy departments, especially those institutions that serve an indigent patient population and are interested in cost-effective management strategies.

Entities:  

Year:  2011        PMID: 25126349      PMCID: PMC4105714     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN: 1942-2962


  9 in total

1.  Using health outcomes data to inform decision-making: formulary committee perspective.

Authors:  R Janknegt
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 2.  Strategies to improve antibiotic use.

Authors:  C S Bryan
Journal:  Infect Dis Clin North Am       Date:  1989-12       Impact factor: 5.982

3.  Antibiotic utilization strategies to limit antimicrobial resistance.

Authors:  Daniel P Raymond; Shawn J Pelletier; Robert G Sawyer
Journal:  Semin Respir Crit Care Med       Date:  2002-10       Impact factor: 3.119

4.  Impact of Modified System of Objectified Judgement Analysis (SOJA) methodology on prescribing costs of ACE inhibitors.

Authors:  Ibrahim Alabbadi; Grainne Crealey; Michael Scott; Simon Baird; Tom Trouton; Jill Mairs; James McElnay
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

Review 5.  InforMatrix: treatment of rheumatoid arthritis using biologicals.

Authors:  Bart J F van den Bemt; Frank H J van den Hoogen; Ferdinand C Breedveld; Hille van der Tempel; Rob Janknegt
Journal:  Expert Opin Pharmacother       Date:  2006-09       Impact factor: 3.889

6.  The effect of health insurance disparities on the health care system.

Authors:  Julia A Thompson; Veronikia Lee
Journal:  AORN J       Date:  2007-11       Impact factor: 0.676

Review 7.  The System of Objectified Judgement Analysis (SOJA). A tool in rational drug selection for formulary inclusion.

Authors:  R Janknegt; A Steenhoek
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

8.  Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes.

Authors:  A C White; R L Atmar; J Wilson; T R Cate; C E Stager; S B Greenberg
Journal:  Clin Infect Dis       Date:  1997-08       Impact factor: 9.079

9.  Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years.

Authors:  Philip Carling; Teresa Fung; Ann Killion; Norma Terrin; Michael Barza
Journal:  Infect Control Hosp Epidemiol       Date:  2003-09       Impact factor: 3.254

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.